prasterone · Millicent · NDA 208470
Intrarosa
Earliest generic entry, as listed
19 Mar 2031
Blocked by patent: US 8268806.
Listed patents · 3 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 8268806 | product | 19 Mar 2031 |
| US 8957054 | use U-1922 | 8 Jan 2030 |
| US 8629129 | product | 7 Aug 2028 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 208470 · 001 · RLD | insert, vaginal | 6.5MG | 19 Mar 2031 |